News Page - Gavi CSO Constituency

Skip to content

[email protected]
[email protected]

Linkedin Twitter Spotify

Home
About Us
Initiatives
Explore the CSO
- Coming Soon
News & Events
Contact Us

Menu

Home
About Us
Initiatives
Explore the CSO
- Coming Soon
News & Events
Contact Us

Our News Hub

Connecting you to CSO news and updates from partner organisations

All News

News

Dyadic International, Inc. Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent

April 17, 2023

News

Accelerating action on Africa’s health agenda: Here’s everything you need to know

April 14, 2023

News

Ghana first to approve Oxford’s malaria vaccine

April 12, 2023

News

Team Europe delivers over 1.5 million COVID-19 vaccines to Nepal through COVAX

April 12, 2023

News

Moderna to establish Kenyan vaccine facility

April 12, 2023

News

Moderna eyes local COVID vaccines for Japan, other countries

April 12, 2023

Events

World TB Day
24 March

March 24, 2023

News

Spain to co-host 2023 Vaccine Alliance High-Level Summit on Immunisation

March 6, 2023

News

African leaders call for urgent action to revitalize routine immunization

February 19, 2023

News

Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO – February 2023

February 14, 2023

News

Dr. Muhammad Ali Pate to become next CEO of Gavi, the vaccine Alliance

February 13, 2023

News

How Bangladesh’s immunisation system is coming back stronger

January 5, 2023

« Previous Next »

Helping Reach Every Child

Join Us.
Become a member

Since its inception in 2000, Gavi has helped to immunise a whole generation – over 888 million children – and prevented more than 15 million future deaths, helping to halve child mortality in 73 lower-income countries.

Linkedin Twitter Spotify

Quick Links

Browse the CSO list
Civil Society Dialogue series
Immunization Podcast

Explore the CSO

Don’t miss our future updates! Get Subscribed Today!

Search

©2024. Gavi CSO Constituency. All Rights Reserved.